Potential Partner Information |
- To ensure your request is directed to the right business and data integration team, please ensure you complete all the questions on the application form as fully as possible.
- Once you have spoken to a member of the business team, MIMS Australia will send you a Mutual Non-Disclosure Agreement (MNDA) and provide more information to help you understand the process for access and evaluation of the data.
- There is an initial one-off integration / conformance fee for all partner applicants for MIMS technical and clinical assistance with integrating the MIMS Medicines Database into a third-party application. This will be charged prior to you being provided with access to any of the MIMS data and is non-refundable. Your relevant BDM will be happy to discuss this further.
- Please read the MNDA documents carefully then sign and return a scanned copy of the MNDA marked to the attention of: Your relevant Business Development Manager (BDM).
- Once the MNDA has been signed and returned, we will introduce you to our Solutions Delivery / Data Integration Team. This team will organise a workshop to discuss the MIMS data base in detail, gather your integration requirements and help with any issues or concerns you may have. The team will also stay in touch throughout your development to support you through the process, and guide on how to best integrate the data.
- Permission for use of the MIMS data base for development is granted for 6 months. After this six-month period if we have not heard from you, your access will be terminated. If you require access for a longer period, you will need to apply for an extension by contacting your BDM.
- During your development/integration, your BDM will be working with you or your nominated business contact to agree on commercials and licensing of the MIMS data and the on-going annual fees.
- Once the MNDA has been signed by both parties we are happy to discuss the commercials and advise you of this before you start the development. It is your responsibility to ensure you fully understand our fee structure and how it fits into your business model.
- The provision of ongoing Monthly updated MIMS data is contingent on two important steps that must be taken prior to deployment of your final integration of our data base to your end users:
1. All licensing agreements and commercials between MIMS and your organisation must have been negotiated, agreed to and the Licence Agreement signed by both parties
2. The MIMS Data Team must review and approve the integration of MIMS data within your software.
Once everything has been completed, you will be notified in writing of the approval to deploy your software with MIMS integrated data.
Once everything has been completed, you will be notified in writing of the approval to deploy your software with MIMS integrated data.
MIMS Australia
Suite 1602, 44 Market Street
Sydney
NSW 2000
+61 2 9902 7700
www.mims.com.au